
This site is no longer maintained as of January 16th, 2013. Due to the increased security risks of this out-dated application , it will be decommissioned July 1st 2013. Please migrate use over to its replacement http://bioconnect.bio5.org. Direct questions and concerns to bio5admin@bio5.org. Thank you.
Displaying 17 - 24 of 115
<< first
< prev |
1 |
2 |
[3] |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
next >
last >>
Kwei KA, Finch JS, Ranger-Moore J, Bowden GT. Jan 2006. The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells. Cancer Lett, 231:326-38
Bair EL, Nagle RB, Ulmer TA, Laferte S, Bowden GT. Feb 2006. 90K/Mac-2 binding protein is expressed in prostate cancer and induces promatrilysin expression. Prostate, 66:283-93
Silvers AL, Finch JS, Bowden GT. Mar 2006. Inhibition of UVA-induced c-Jun N-terminal Kinase Activity Results in Caspase-dependent Apoptosis in Human Keratinocytes. Photochem Photobiol, 82:423-31
Finch JS, Tome ME, Kwei KA, Bowden GT. Mar 2006. Catalase reverses tumorigenicity in a malignant cell line by an epidermal growth factor receptor pathway. Free Radic Biol Med, 40:863-75
Degner SC, Kemp MQ, Bowden GT, Romagnolo DF. Feb 2006. Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J Nutr, 136:421-7
Tu VC Sun H Bowden GT Chen QM. Nov 2006. Involvement of Oxidants and AP-1 in Angiotensin II Activated NFAT3 Transcription Factor. Am J Physiol Cell Physiol,2006 Nov 15;
Displaying 17 - 24 of 115
<< first
< prev |
1 |
2 |
[3] |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
next >
last >>